Prevention of Recurrent Rheumatic Fever

Regimen for Antibiotic Prophylaxis

• The American Heart Association recommends benzathine penicillin G 1.2 million units intramuscularly every 4 weeks as the first-line regimen with the strongest evidence (Class I, LOE A) for preventing recurrent rheumatic fever in patients with a history of rheumatic fever, particularly those with high-risk profiles or those who have experienced recurrence despite adherence to the 4-week regimen 1, 2, 3
• For high-risk populations or patients with recurrence despite adherence to the 4-week regimen, consider administering benzathine penicillin G every 3 weeks 1, 2, 3
• The American College of Cardiology suggests that benzathine penicillin G is approximately 10 times more effective than oral antibiotics in preventing recurrence (0.1% vs 1%) 1, 2
• For patients allergic to penicillin, the American Heart Association recommends penicillin V oral 250 mg twice daily (for children) or 500 mg 2-3 times daily (for adolescents/adults) as an alternative 1, 2, 3
• Sulfadiazine oral 1 gram once daily (for adults) or 0.5 gram once daily for patients weighing ≤27 kg is also an alternative for patients allergic to penicillin 1, 2

Duration of Prophylaxis Based on Severity

• For patients with rheumatic fever and carditis, the American College of Cardiology recommends prophylaxis for 10 years after the last attack or until age 40 (whichever is longer) 1, 2, 3
• For patients with rheumatic fever and carditis but without residual heart disease, the American Heart Association suggests prophylaxis for 10 years after the last attack or until age 21 (whichever is longer) 1, 2, 3
• For patients with rheumatic fever without carditis, the American College of Cardiology recommends prophylaxis for 5 years after the last attack or until age 21 (whichever is longer) 1, 2, 3

Management of Acute Episodes

• The American Heart Association recommends a full course of penicillin therapy to eradicate residual Streptococcus group A, even if throat culture is negative at diagnosis 1, 3, 4
• Initiate long-term antimicrobial prophylaxis as soon as acute rheumatic fever is diagnosed 1, 4

Important Clinical Considerations

• The American College of Cardiology states that long-term antimicrobial prophylaxis provides the most effective protection against recurrent rheumatic fever 1
• At least one-third of rheumatic fever cases arise from asymptomatic Streptococcus group A infections, making prevention challenging 4
• Even when Streptococcus group A pharyngitis is optimally treated, rheumatic fever can still occur in susceptible individuals 4

Prevention of Endocarditis

• The American Heart Association no longer recommends routine endocarditis prophylaxis for patients with rheumatic heart disease, unless they have prosthetic valves or prosthetic material used in valve repair 2, 5
• For patients who have received penicillin prophylaxis for rheumatic fever and require endocarditis prophylaxis for dental procedures, use an agent other than penicillin due to the possibility of oral α-hemolytic streptococci developing resistance to penicillin 3, 5

Risk of Recurrence

• The risk of recurrence increases with multiple previous attacks, while the risk decreases with increasing interval since the last attack 1
• Individuals with high exposure to streptococcal infections, including children and adolescents, parents of young children, teachers, healthcare workers, and military recruits, are at higher risk of recurrence 1
• A higher risk of recurrence has been demonstrated in economically disadvantaged populations 1

Rheumatic Heart Disease Prophylaxis in Children

Alternative Regimens for Penicillin Allergy

• The American Heart Association recommends penicillin V oral: 250 mg twice daily (Class I, Level of Evidence B) for children with a documented penicillin allergy 6, 7
• The American Heart Association recommends sulfadiazine oral: 0.5 g once daily for children weighing ≤27 kg (60 lb) (Class I, Level of Evidence B) for children with a documented penicillin allergy 6, 7
• The American Heart Association recommends macrolides (erythromycin or clarithromycin) or azalides (azithromycin) for patients allergic to both penicillin and sulfonamides (Class I, Level of Evidence C) 6, 7

Common Pitfalls to Avoid

• The American Heart Association advises against switching to oral prophylaxis prematurely, and considers switching only when patients reach late adolescence or young adulthood AND have remained free of rheumatic attacks for at least 5 years (Class IIb, Level of Evidence C) 6, 7

Benzathine Penicillin G Secondary Prophylaxis for Rheumatic Heart Disease

Standard Regimen and Evidence

• The American College of Cardiology recommends benzathine penicillin G 1.2 million units intramuscularly every 4 weeks as the standard secondary‑prophylaxis regimen for patients with rheumatic heart disease. This first‑line regimen carries the strongest evidence (Class I, Level A) for preventing recurrent rheumatic fever. 8

High‑Risk Dosing Adjustments

• In high‑risk situations—such as populations with very high rheumatic fever incidence, patients who experience recurrent acute rheumatic fever despite documented adherence to the 4‑week schedule, or when serum penicillin levels are expected to fall below protective thresholds before the fourth week—the American College of Cardiology advises increasing the dosing frequency to benzathine penicillin G 1.2 million units intramuscularly every 3 weeks. 8

Duration of Prophylaxis Based on Cardiac Involvement

• The duration of secondary prophylaxis is determined by the severity of cardiac involvement at the time of the last acute rheumatic fever episode. 8

• Rheumatic fever with carditis and persistent valvular disease: continue prophylaxis for 10 years after the last attack or until age 40 years, whichever is longer; consider lifelong prophylaxis if the patient remains at high risk for group A streptococcal exposure. 8

• Rheumatic fever with carditis but no residual heart disease: continue prophylaxis for 10 years after the last attack or until age 21 years, whichever is longer. 8

• Rheumatic fever without carditis: continue prophylaxis for 5 years after the last attack or until age 21 years, whichever is longer. 8

Alternative Regimens for Penicillin Allergy

• For patients allergic to penicillin, the American College of Cardiology recommends oral penicillin V 250 mg twice daily for children or 500 mg two‑to‑three times daily for adolescents and adults. 8

• When sulfonamides are tolerated, sulfadiazine 1 g once daily for adults (or 0.5 g once daily for patients ≤27 kg) is an alternative oral regimen. 8

• For patients allergic to both penicillin and sulfonamides, macrolides (erythromycin or clarithromycin) or azalides (azithromycin) may be used at appropriate doses. 8

• Safety caveat: macrolide antibiotics should be avoided in individuals receiving strong cytochrome P450 3A inhibitors (e.g., azole antifungals, HIV protease inhibitors, and certain selective serotonin reuptake inhibitors). 8

Benzathine Penicillin G Secondary Prophylaxis for Rheumatic Heart Disease – Evidence‑Based Recommendations

First‑Line Oral Alternatives (Penicillin‑Allergic Patients)

• Penicillin V 250 mg orally twice daily for pediatric patients; 500 mg orally two to three times daily for adolescents and adults (Class I, Level B) 9
• Sulfadiazine 1 g orally once daily for adult patients; 0.5 g orally once daily for patients weighing ≤27 kg (Class I, Level B) 9

Second‑Line Alternatives (Allergy to Penicillin and Sulfonamides)

• Macrolides (erythromycin or clarithromycin) or azalide (azithromycin) are recommended (Class I, Level C) 9
• These macrolides should be avoided in patients receiving strong CYP3A4 inhibitors (e.g., azole antifungals, HIV protease inhibitors, certain SSRIs) because of the risk of QT‑interval prolongation and drug interactions 9

Pregnancy Considerations

• Sulfonamide agents are contraindicated in late pregnancy due to transplacental passage and competition with bilirubin for albumin‑binding sites 9
• During pregnancy, continue benzathine penicillin G or switch to penicillin V if sulfonamides were being used 9

Endocarditis Prophylaxis

• Routine antibiotic prophylaxis for endocarditis is no longer recommended for patients with rheumatic heart disease unless they have prosthetic valves or prosthetic material used in valve repair 9
• When dental procedures require endocarditis prophylaxis in patients already on penicillin prophylaxis, an agent other than penicillin should be used because oral α‑hemolytic streptococci are likely penicillin‑resistant 9

Guidance on Switching to Oral Prophylaxis

• Switching to oral prophylaxis should be deferred until the patient reaches late adolescence or young adulthood and has remained free of rheumatic attacks for at least five years (Class IIb, Level C) 9

Adherence and Recurrence Risk

• The majority of prophylaxis failures are attributable to poor adherence; even with optimal adherence, oral prophylaxis carries a higher recurrence risk compared with intramuscular benzathine penicillin G 9

Guideline Recommendations for Rheumatic Heart Disease Prophylaxis During Benzathine Penicillin G Shortages

Efficacy of Intramuscular vs. Oral Prophylaxis

• Intramuscular benzathine penicillin G provides markedly superior protection against rheumatic fever recurrence compared with oral penicillin V; oral prophylaxis is associated with a significantly higher risk of recurrence even when adherence is optimal. (American Heart Association guideline) [10][11]
• The majority of prophylaxis failures occur in patients who are non‑adherent, and switching between intramuscular and oral regimens further complicates adherence. (American Heart Association guideline) 11

Guideline Stance on Alternating Regimens

• No published guideline or evidence endorses alternating between intramuscular benzathine penicillin G and oral penicillin V based on drug availability; such practice is discouraged. (American Heart Association guideline) [10][11]12
• Switching to oral penicillin V during supply gaps creates periods of sub‑optimal protection because oral dosing requires twice‑daily administration and depends entirely on patient adherence. (American Heart Association guideline) [10][11]

Management During Benzathine Penicillin G Shortages

• Primary recommendation: Maintain continuous intramuscular benzathine penicillin G 1.2 million units every 4 weeks (or every 3 weeks for high‑risk patients). (American Heart Association guideline) 12
• Bridge therapy: If benzathine penicillin G is temporarily unavailable, initiate oral penicillin V 250 mg twice daily as a bridge, coupled with intensive patient education on adherence, and resume intramuscular injections as soon as supply is restored. (American Heart Association guideline) [10][11]
• Prohibited practice: Do not create a rotating schedule that alternates oral and intramuscular formulations; alternating regimens should never be planned. (American Heart Association guideline) [10][11]

Risk Stratification and Alternative Therapies

• Oral prophylaxis is appropriate only for patients assessed to be at lower risk of rheumatic fever recurrence. (American Heart Association guideline) [10][11]
• For high‑risk patients or those who experience recurrence despite a 4‑week intramuscular schedule, a more frequent dosing interval of benzathine penicillin G every 3 weeks should be considered when the drug is available. (American Heart Association guideline) 12
• In patients with documented penicillin allergy, sulfadiazine 1 g once daily (or 0.5 g for patients ≤27 kg) is an acceptable alternative that eliminates the need for monthly injections. (American Heart Association guideline) [10][11]12

Permanent Switch to Oral Prophylaxis (When Clinically Appropriate)

• A permanent transition to oral penicillin V may be contemplated for individuals who have reached late adolescence or young adulthood and have remained free of rheumatic attacks for at least 5 years; this is a Class IIb recommendation. (American Heart Association guideline) [10][11]
• Such a switch must be a deliberate clinical decision based on comprehensive risk stratification, not a reaction to drug‑supply constraints. (American Heart Association guideline) [10][11]